|
National Stock Number(NSN): 6505-01-274-9670 (6505012749670, 012749670)
| NIIN: |
01-274-9670 |
Item Name: |
CEFTIZOXIME INJECTION |
INC: |
66524
|
| FSC: |
6505
|
Assignment Date: |
Mar-16-1988 |
CRIT: |
X |
IIG: |
66524 |
| ISC: |
2 |
Date Standardized: |
Feb-15-1990 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
0 |
Cancellation Date: |
|
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.20.0060 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
2B3515 |
04687
|
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES |
C |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
CEFIZOX |
39832
|
ASTELLAS PHARMA US, INC. |
C |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00469-7221-02 |
39832
|
ASTELLAS PHARMA US, INC. |
C |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC57317-0221-50 |
39832
|
ASTELLAS PHARMA US, INC. |
C |
5 |
9 |
4 |
KX |
|
B |
|
|
|
|
|
9-1241 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
CEFIZOX |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
CEFIZOX |
0M2V3
|
FUJISAWA PHARMACEUTICAL CO |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
CEFIZOX |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
CEFIZOX INJECTION PREMIXED |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00007-3321-04 |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC57317-0221-50 |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NDC57317-0221-50 |
0M2V3
|
FUJISAWA PHARMACEUTICAL CO |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
Y |
|
M |
U |
1 |
A |
$654.82 |
PG |
|
C2201X- |
Oct-01-2025 |
C |
| DF |
SMS |
Y |
|
M |
U |
1 |
F |
$654.82 |
PG |
|
------- |
Oct-01-2025 |
C |
| DN |
SMS |
Y |
|
M |
U |
1 |
N |
$844.23 |
PG |
|
9B----A |
Oct-01-2024 |
H |
| DS |
SMS |
L |
|
M |
U |
1 |
D |
$787.86 |
PG |
|
------- |
Oct-01-2022 |
H |
| DS |
SMS |
Y |
|
M |
U |
1 |
I |
$654.82 |
PG |
|
------- |
Oct-01-2025 |
C |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 24 EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 24 EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 24 EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 24EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 24 EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AJCN |
PROTECTIVE STORAGE FEATURE |
MUST BE FROZEN |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.000 GRAMS CEFTIZOXIME EQUIVALENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BAG WITH HANGING DEVICE, PLASTIC |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
50.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
24 |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
CEFTIZOXIME INJECTION 50ML BAG 24S |
| FEAT |
SPECIAL FEATURES |
PRESERVATIVE FREE; BAGS W/HANGER STRAP AND PERMANTNTLY ATTACHED OUTLET PORT; NON-PYROGENIC; USE W/STOCK LISTED INJECTION SETS |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| SUPP |
SUPPLEMENTARY FEATURES |
2GM CEFTIZOMINE EQUIVALENT; 50ML IN BAG W/HANGING DEVICE; PLASTIC; 24 BAGS PER PACKAGE; PREMIXED IN 5% DEXTROXE (D5W); FROZEN; SINGLE DOSE; BAGS W/HANGER STRAP |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
A111 |
Dec-01-2006 |
3 |
Z |
|
|
AM|GX |
AM|BN|GX |
| FSGM |
FSKX |
Dec-01-2006 |
3 |
Z |
|
|
GX|TT |
GX|SS|TT |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
KX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
532 |
| Type of Cargo Code: |
H |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MW |
Air Dimension Code: |
A |
| Source: |
P |
Primary Inventory Control Activity (PICA) |
Status: |
C |
| Pri/Sec ICC: |
P |
Container NSN: |
|
Category Code: |
ZZZZ |
| Lvl A Pkg Req: |
Z |
Unit Pack Size: |
|
Pres Material: |
ZZ |
| Lvl B Pkg Req: |
|
Unit Pack Weight: |
0.0 |
Pres Method: |
ZZ |
| Lvl C Pkg Req: |
|
Unit Pack Cube: |
0.000 |
Wrapping Mat: |
ZZ |
| Opt Proc Ind: |
M |
Unpkg Item Dims: |
|
Spec Marking: |
ZZ |
| Supp Inst: |
APPLICABLE TO ALL MEDICAL |
| Container FSC: |
|
SPI Number: |
MPPWN00001 |
SPI Revision: |
|
| Unpkg Weight: |
|
SPI Date: |
Mar-30-1988 |
Pkg Design Activity: |
89875
|
| Inter Container Qty: |
|
Inter Container Code: |
|
Clean/Dry Procedure: |
Z |
| Unit Container: |
ZZ |
Item Type Storage: |
|
Unit Container Level: |
|
| |
|
Cush/Dun Material: |
ZZ |
Cush/Dun Thickness: |
Z |
|